Mouse models of genetic effects on cognition: relevance to schizophrenia.
about
A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Neural structures underlying set-shifting: roles of medial prefrontal cortex and anterior cingulate cortexProphylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant miceThe involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.Microendophenotypes of psychiatric disorders: phenotypes of psychiatric disorders at the level of molecular dynamics, synapses, neurons, and neural circuitsMouse models of gene-environment interactions in schizophrenia.Comprehensive behavioural analysis of Long Evans and Sprague-Dawley rats reveals differential effects of housing conditions on tests relevant to neuropsychiatric disorders.Reduced expression of STOP/MAP6 in mice leads to cognitive deficitsModeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.New insights into behaviour using mouse ENU mutagenesisReversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice.Trial-unique, delayed nonmatching-to-location (TUNL) touchscreen testing for mice: sensitivity to dorsal hippocampal dysfunction.SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments.Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.Neurodevelopment, GABA system dysfunction, and schizophreniaThe dynamics of DNA methylation in schizophrenia and related psychiatric disorders.Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression.Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behaviorDISC1 genetics, biology and psychiatric illnessNMDA hypofunction as a convergence point for progression and symptoms of schizophreniaEpistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humansCocaine Self-Administration Elevates GluN2B within dmPFC Mediating Heightened Cue-Elicited Operant RespondingKCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia.Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield".Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatmentBehavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.Cellular and circuit models of increased resting-state network gamma activity in schizophreniaNMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?The effect of dopamine D4 receptor density on novelty seeking, activity, social interaction, and alcohol binge drinking in adult mice.The role of the dorsal hippocampus in two versions of the touchscreen automated paired associates learning (PAL) task for mice.The continuous performance test (rCPT) for mice: a novel operant touchscreen test of attentional function.Schizophrenia: What's Arc Got to Do with It?Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex.Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia.Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.Altered resonance properties of somatosensory responses in mice deficient for the schizophrenia risk gene Neuregulin 1.
P2860
Q27001119-ECAE1CF7-849F-4027-B456-8E2B0CAAFBD3Q27008180-E828BC14-8BA9-4571-96A4-F0B658166D33Q28484428-73E36633-5274-485B-A0C8-F5AEBB1389A6Q30362017-DFFF7351-D5CE-4F99-A381-528D3F1C6EE5Q30409099-66C20533-EEC5-4429-89EA-E7B94BE60507Q30432026-C7D5F28B-6923-4A0A-A33F-AEE19B9EB816Q30441099-75A41FB2-6FE1-406A-B528-06647A6A7A61Q30450182-7B241E5C-B4F8-4B7A-B56F-9C2F6F8CFE79Q30454958-C7991D4C-464D-4F54-969E-65FE0AF8F3FDQ30463349-C07B9E97-337C-4A2F-A3E5-A7B3A95C9BD0Q30467877-FE5E53A1-2A7F-4D16-B70F-912014A28A2EQ30667486-065E1572-F020-480D-A6DC-5B6CCFD103D3Q30838734-31C2EDD5-B7BD-4939-ADB6-F80DB69C05D3Q33945211-1D6C570C-8284-47D5-9AF8-E049DB2FFA86Q34675943-B1D19B4C-DB25-485E-972E-5D5BC4D6F748Q36465820-7A4B9A43-A642-497B-9AEE-59CBA3295B81Q36540020-E1439F8F-DB99-4A99-927E-5E6360C7EE5DQ36566216-97D3A5D1-D411-4E56-9053-B578B84FB60EQ36634401-D1A0FE64-2C92-418B-85F5-CA13B9010F66Q36718684-DBA2114E-EECD-4EC0-9B9A-D32E4C29412CQ36837668-DEFEB5C3-4683-4176-AB00-C2B1E2F076A4Q37130682-0DEDDD8C-E76A-4BFE-B6D4-896E7A500358Q37165829-EED27664-03B5-4420-840E-2D8B92FAD178Q37670805-5550E241-5FCE-4556-B373-A8E226C2E3ECQ38008577-05731F1D-574D-4555-9D21-6444FE93FA1EQ38110180-7E2AAAAE-29E8-4344-B96D-4A6F75F1B43FQ38133757-2403BDA8-5F35-4812-BB1A-FA3F09372847Q38213709-BA1E0F2D-3260-4310-A36A-6D9CC91F39E4Q38281865-4AFA4D63-505B-4A00-A4ED-3A2BCC763334Q38636247-06A1DC8A-6144-4984-A07B-E988FA18299BQ38821460-F8DBEBE0-C265-4BB1-B62A-D1C9EAEC0D04Q39013931-7AEF7AEB-9076-4DF3-860E-7E046601B245Q42046268-774A93EA-57D7-4CB7-B614-12F246F0C500Q42131941-064B4830-3786-431E-B5B1-2A96351212F0Q42363268-2CD0659C-AA78-4411-A7B7-25C9F814BC89Q46395989-8D119D57-960C-4217-A1A5-B83BC6F415E5Q47406216-789B51C1-D2B8-4B43-B43F-A9F7BB908109Q48520616-ACE61AC9-6152-4C80-B4C7-E65FA9B5E283Q49065170-5829707E-9A0D-4908-BDF0-47DAF7A08692
P2860
Mouse models of genetic effects on cognition: relevance to schizophrenia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@ast
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@en
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@nl
type
label
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@ast
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@en
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@nl
prefLabel
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@ast
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@en
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@nl
P1433
P1476
Mouse models of genetic effects on cognition: relevance to schizophrenia.
@en
P2093
Barbara K Lipska
Francesco Papaleo
P304
P356
10.1016/J.NEUROPHARM.2011.04.025
P577
2011-05-05T00:00:00Z